BianoGMP GmbH’s Post

Keynote Speaker: Annemieke Aartsma-Rus 20th Annual Meeting of the Oligonucleotide Therapeutics Society PI & Professor of Translational Genetics Dept. of Human Genetics, Leiden University Medical Center Prof. Dr. Aartsma-Rus played an important role in the development of antisense mediated exon skipping for Duchenne muscular dystrophy during her PhD research (2000-2004) at the LUMC, co-founded the Dutch Center for RNA Therapeutics (DCRT), and is a board member of the N-of-1 collaborative (N1C), a global umbrella organization aiming to facilitate development of antisense oligonucleotide therapies for patients with very rare, eligible mutations. OTS was proud to have Dr. Aartsma-Rus as president of the Oligonucleotide Therapeutics Society from 2019-2021. She is currently a co-editor-in-chief for Nucleic Acid Therapeutics, OTS' official journal. Dr. Aartsma-Rus will deliver the keynote presentation at the OTS Annual Meeting on Sunday, October 6th, drawing from her extraordinary insights from decades of groundbreaking research in therapeutic applications. For more information about Prof. Dr. Annemieke Aartsma-Rus, read her bio: https://lnkd.in/gXsgtqD5 Registration for the event is available at the same link. #ots24 #ots #oligomeeting #oligotherapeutics #oligonucleotide #biotechnology #science #research #montreal #pharmaceuticals #networking #keynote #annemiekeaartsmarus